Trump's Pharmaceutical Sales Overhaul Benefits Son's Company and Cabinet Member

Trump’s proposed direct pharmaceutical sales to consumers would specifically benefit BlinkRx, where Donald Trump Jr. serves on the board, and Cantor Fitzgerald, connected to Commerce Secretary Howard Lutnick’s family. The policy change represents textbook corruption: government officials …